Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opiate antagonists in shock.

C J Hinds

    British Journal of Hospital Medicine
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Naloxone, an opioid antagonist, was found to prevent and reverse endotoxin-induced hypotension in rats. This discovery spurred research into using endogenous opioid peptides for treating shock.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dynamic preload markers to predict fluid responsiveness during and after major gastrointestinal surgery: an observational substudy of the OPTIMISE trial.

    British journal of anaesthesia·2014
    Same author

    Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.

    Intensive care medicine·2013
    Same author

    Mortality and utilisation of critical care resources amongst high-risk surgical patients in a large NHS trust.

    Anaesthesia·2008
    Same author

    Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling.

    Infection and immunity·2005
    Same author

    Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care.

    Anaesthesia·2005
    Same author

    TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study.

    Genes and immunity·2004
    Same journal

    The autopsy in the 1990s.

    British journal of hospital medicine·1999
    Same journal

    Screening for breast cancer.

    British journal of hospital medicine·1999
    Same journal

    Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

    British journal of hospital medicine·1999
    Same journal

    Liposarcoma: a review of current diagnosis and management.

    British journal of hospital medicine·1999
    Same journal

    How to do it in surgery: laparoscopic rectopexy.

    British journal of hospital medicine·1999
    Same journal

    The management of ovarian cancer.

    British journal of hospital medicine·1999
    See all related articles

    Area of Science:

    • Pharmacology
    • Physiology
    • Critical Care Medicine

    Background:

    • Endotoxin-induced hypotension in rats was observed to be preventable and reversible by naloxone in 1978.
    • This finding initiated investigations into the role of endogenous opioid peptides in shock management.

    Purpose of the Study:

    • To review and contextualize the research on endogenous opioid peptides in shock treatment over the past eight years.

    Main Methods:

    • Literature review of studies published in the last 8 years.
    • Analysis of the role of endogenous opioid peptides in shock models.

    Main Results:

    • The potential therapeutic applications of endogenous opioid peptides in shock have been extensively scrutinized.

    Related Experiment Videos

  • Research has focused on understanding the mechanisms by which these peptides influence hemodynamic stability.

    • Conclusions:

    • The review provides a perspective on the progress and findings in the field over the specified period.
    • Further research is warranted to fully elucidate the therapeutic potential of endogenous opioid peptides in managing shock.